Vestnik dermatologii i venerologiiVestnik dermatologii i venerologiiВестник дерматологии и венерологии0042-46092313-6294Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov46210.25208/0042-4609-2019-95-1-15-20REVIEWSОБЗОР ЛИТЕРАТУРЫSneddon — Wilkinson disease: Review of the modern literatureСубкорнеальный пустулез Снеддона — Уилкинсона: Обзор современной литературыhttps://orcid.org/0000-0002-7689-8350DrozhdinaM. B.ДрождинаМ. Б.
Russian Federation

Cand. Sci. (Med.), Associate Professor, Department of Dermatovenereology and Cosmetology

к.м.н., доцент, доцент кафедры дерматовенерологии и косметологии

drozhdina@yandex.ruhttps://orcid.org/0000-0002-6220-8304KoshkinS. V.КошкинС. В.
Russian Federation

Dr. Sci. (Med.), Prof., Departmental Head, Department of Dermatovenereology and Cosmetology

д.м.н., доцент, профессор, заведующий кафедрой дерматовенерологии и косметологии

koshkin_sergei@mail.ruKirov State Medical University, Ministry of Health of the Russian FederationКировский государственный медицинский университет Министерства здравоохранения Российской Федерации0203201995115203005201930052019Copyright ©; 2019, Drozhdina M.B., Koshkin S.V.Copyright ©; 2019, Дрождина М.Б., Кошкин С.В.2019Drozhdina M.B., Koshkin S.V.Дрождина М.Б., Кошкин С.В.https://creativecommons.org/licenses/by/4.0https://vestnikdv.ru/jour/article/view/462

The article provides a current overview of the correlation between a rare dermatosis — subcorneal pustulosis (Sneddon — Wilkinson disease) — and various diseases of internal organs; features of immunological changes; the role of desmocollin 1, chemoatractants, interleukin-1β, interleukin-6, interleukin-8, interleukin-10, leukotriene B4, tumour necrosis factor-alpha and K5a complement fraction in the pathogenesis of the disease. In this work, the authors describe the features of the clinical picture of the disease, as well as diagnostic criteria, including the use of serum protein electrophoresis. Histological features of the disease are discussed in detail. In addition, modern methods for treating this disease, including the use of dapsone, acitretin, infliximab, PUVA therapy are presented.

В статье описаны современные данные о взаимосвязи редкого дерматоза, субкорнеального пустулеза Снеддона — Уилкинсона, с различными заболеваниями внутренних органов, об особенностях иммунологических изменений, роли десмоколлина-1, хемоаттрактантов, интерлейкина-1β, интерлейкина-6, интерлейкина-8, интерлейкина-10, лейкотриена В4, фактора некроза опухоли-альфа и фракции К5а комплемента в патогенезе заболевания. Описаны особенности клинической картины заболевания, критерии диагностики, включая применение электрофореза сывороточного протеина. Подробно обсуждены гистологические особенности заболевания. Представлены современные методики лечения данного заболевания, включая применение дапсона, ацитретина, инфликсимаба, ПУВА-терапии.

subcorneal pustular dermatosisIgA monoclonal gammopathydesmocollin 1chemoattractantsinterleukin-1βinterleukin-6interleukin-8interleukin-10leukotriene B4tumor necrosis factorserum protein electrophoresisdapsoneсубкорнеальный пустулезIgA-моноклональная гаммапатиядесмоколлин-1хемоаттрактантыинтерлейкин-1βинтерлейкин-6интерлейкин-8интерлейкин-10лейкотриен В4фактор некроза опухолиэлектрофорез сывороточного протеинадапсон1. Sneddon I. B., Wilkinson D. S. Subcorneal pustular dermatosis. Br J Dermatol. 1956 Dec.;68(12):385–394. DOI: 10.1111/j.1365-4362.1977. tb01874.x2. Sneddon I. B., Wilkinson D. S. Subcorneal pustular dermatosis. Br J Dermatol. 1979Jan.;100(1):61–68. DOI: 10.1111/j.1365-2133.1979. tb03570.x3. Bordignon M., Zattra E., Montesco M. C., Alaibac M. Subcorneal pustular dermatosis (Sneddon — Wilkinson disease) with absence of desmoglein 1 and 3 antibodies: case report and literature review. Am J Clin Dermatol. 2008;9(1):51–55. DOI: 10.2165/00128071-200809010-000064. Ono S., Otsuka A., Miyachi Y., Kabashima K. Subcorneal Pustular Dermatosis Exhibiting a High Serum TARC/CCL17 Level. Case Rep Dermatol. 2013 Jan.;5(1):38–42. DOI: 10.1159/0003482415. Hashimoto T., Teye K., Ishii N. Clinical and immunological studies of 49 cases of various types of intercellular IgA dermatosis and 13 cases of classical subcorneal pustular dermatosis examined at Kurume University. Br J Dermatol. 2016 Jun 3. DOI: 10.1111/bjd.147806. Kasha E. E. Jr., Epinette W. W. Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) in association with a monoclonal IgA gammopathy: a report and review of the literature. J Am Acad Dermatol. 1988 Nov.;19(5 Pt 1):854–858.7. Cohen P. R. Neutrophilic dermatoses: a review of current treatment options. Am J Clin Dermatol. 2009;10(5):301–312. DOI: 10.2165/11310730-000000000-000008. Naik H. B., Cowen E. W. Autoinflammatory pustular neutrophilic diseases. Dermatol Clin. 2013 Jul.;31(3):405–425. DOI: 10.1016/j. det.2013.04.0019. Puechguiral-Renaud I., Carpentier O., Piette F., Delaporte E. Subcorneal pustulosis and Pyoderma gangrenosum associated with a biclonal gammopathy. Eur J Dermatol. 2006 Nov-Dec.;16(6):687–690. DOI: 10.2165/00128071-200809010-0000610. Takata M., Inaoki M., Shodo M., Hirone T., Kaya H. Subcorneal pustular dermatosis associated with IgA myeloma and intraepidermal IgA deposits. Dermatology. 1994:189(Suppl 1):111–114. DOI: 10.1159/00024694711. Butt A., Burge S. M. Sneddon — Wilkinson disease in association with rheumatoid arthritis. Br J Dermatol. 1995 Feb.;132(2):313–315.12. García-Salces I., Baldellou R., Hörndler C., Zubiri M. L. Subcorneal pustular dermatosis with pathergy phenomenon in a patient with Crohn’s disease. J Eur Acad Dermatol Venereol. 2009 Mar.;23(3):349–350. DOI: 10.1111/j.1468-3083.2008.02866.x13. Voigtlander C., Luftl M., Schuler G., Hertl M. Infliximab (antitumor necrosis factor alpha antibody): a novel, highly effective treatment of recalcitrant subcorneal pustular dermatosis (Sneddon — Wilkinson disease). Arch Dermatol. 2001 Dec.;137(12):1571–1574. DOI: 10.1001/archderm.137.12.157114. Bonifati C., Trento E., Cordiali Fei P., Muscardin L., Amantea A., Carducci M. Early but not lasting improvement of recalcitrant subcorneal pustular dermatosis (Sneddon — Wilkinson disease) after infliximab therapy: relationships with variations in cytokine levels in suction blister fluids. Clin Exp Dermatol. 2005 Nov.;30(6):662–665. DOI: 10.1111/j.1365-2230.2005.01902.x15. Scarpa R., Lubrano E., Cozzi R., Ames P. R., Oriente C. B., Oriente P. Subcorneal pustular dermatosis (Sneddon — Wilkinson syndrome): another cutaneous manifestation of SAPHO syndrome? Br J Rheumatol. 1997 May;36(5):602–603. DOI: 10.1093/rheumatology/36.5.60216. Park B. S., Cho K. H., Eun H. C., Youn J. I. Subcorneal pustular dermatosis in a patient with aplastic anemia. J Am Acad Dermatol. 1998 Aug.;39(2 Pt 1):287–289. DOI: 10.1016/S0190-9622(98)70093-317. Lombart F., Dhaille F., Lok C., Dadban A. Subcorneal pustular dermatosis associated with Mycoplasma pneumoniae infection. J Am Acad Dermatol. 2014 Sep.;71(3):85–86. DOI: 10.1016/S0190-9622(98)70093-318. Iyengar S., Chambers C. J., Chang S., Fung M. A., Sharon V. R. Subcorneal pustular dermatosis associated with Coccidioides immitis. Dermatol Online J. 2015 Aug 15;21(8).19. Taniguchi S., Tsuruta D., Kutsuna H., Hamada T. Subcorneal pustular dermatosis in a patient with hyperthyroidism. Dermatology. 1995;190(1):64–66. DOI: 10.1159/00024663820. Agarwal A., Shivaswamy K. N., Barani R. et al. Subcorneal pustular dermatosis and thymoma: an association or a coincidence? Indian J Dermatol. 2006;51:272–274.21. Bauwens M., De Coninck A., Roseeuw D. Subcorneal pustular dermatosis treated with PUVA therapy. A case report and review of the literature. Dermatology. 1999;198(2):203–205.22. Marliere V., Beylot-Barry M., Beylot C., Doutre M. Successful treatment of subcorneal pustular dermatosis (Sneddon — Wilkinson disease) by acitretin: report of a case. Dermatology. 1999;199(2):153–155. DOI: 10.1159/00001822423. Kawaguchi M., Mitsuhashi Y., Kondo S. A case of subcorneal pustular dermatosis treated with tacalcitol (1alpha, 24-dihydroxyvitamin D3). J Dermatol. 2000 Oct.;27(10):669–672.24. Hoshina D., Tsujiwaki M., Furuya K. Successful treatment of subcorneal pustular dermatosis with maxacalcitol. Clin Exp Dermatol. 2016 Jan.;41(1):102–103. DOI: 10.1111/ced.1268025. Kono T., Terashima T., Oura H., Ishii M., Taniguchi S., Muramatsu T. Recalcitrant subcorneal pustular dermatosis and bullous pemphigoid treated with mizoribine, an immunosuppressive, purine biosynthesis inhibitor. Br J Dermatol. 2000 Dec.;143(6):1328–1330. DOI: 10.1046/j.1365-2133.2000.03917.x26. Verma K. K., Pasricha J. S. Ketoconazole as a therapeutic modality in subcorneal pustular dermatosis. Acta Derm Venereol. 1997 Sep.;77(5):407–408.27. Ayres S. Jr., Mihan R. Letter: Subcorneal pustular dermatosis controlled by vitamin E. Arch Dermatol. 1974 Jun.;109(6):914. DOI: 10.1001/ archderm.109.6.914b28. Bliziotis I., Rafailidis P., Vergidis P., Falagas M. E. Regression of subcorneal pustular dermatosis type of IgA pemphigus lesions with azithromycin. J Infect. 2005 Aug.;51(2):E31–E34. DOI: 10.1016/j.jinf.2004.08.00929. Zachariae C. O., Rossen K., Weismann K. An unusual severe case of subcorneal pustular dermatosis treated with cyclosporine and prednisolone. Acta Derm Venereol. 2000 Sep-Oct.;80(5):386–387.30. Karadogan S. K., Aydogan K., Baskan E. B., Tunali S. A case of subcorneal pustular dermatosis treated successfully with a combination of cyclosporin and prednisolone. J Eur Acad Dermatol Venereol. 2007 Apr.;21(4):536–537.31. Howell S. M., Bessinger G. T., Altman C. E., Belnap C. M. Rapid response of IgA pemphigus of the subcorneal pustular dermatosis subtype to treatment with adalimumab and mycophenolate mofetil. J Am Acad Dermatol. 2005 Sep.;53(3):541–543. DOI: 10.1016/j.jaad.2005.02.051